Dalton Investments Inc. Invests $1.03 Million in Trupanion, Inc. (NASDAQ:TRUP)

Dalton Investments Inc. purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUP) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 35,000 shares of the financial services provider’s stock, valued at approximately $1,029,000. Trupanion comprises approximately 0.6% of Dalton Investments Inc.’s holdings, making the stock its 20th biggest position. Dalton Investments Inc. owned about 0.08% of Trupanion at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in TRUP. Victory Capital Management Inc. purchased a new position in Trupanion in the 4th quarter valued at $211,000. Charles Schwab Investment Management Inc. raised its holdings in Trupanion by 2.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 300,029 shares of the financial services provider’s stock worth $9,154,000 after purchasing an additional 7,088 shares in the last quarter. Trexquant Investment LP lifted its position in Trupanion by 177.0% in the fourth quarter. Trexquant Investment LP now owns 76,775 shares of the financial services provider’s stock valued at $2,342,000 after purchasing an additional 49,062 shares during the period. Quest Partners LLC purchased a new stake in Trupanion in the 4th quarter valued at approximately $67,000. Finally, Blueshift Asset Management LLC acquired a new position in Trupanion during the 4th quarter worth approximately $220,000.

Insiders Place Their Bets

In other news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,764 shares of company stock valued at $405,238. Corporate insiders own 5.50% of the company’s stock.

Analyst Upgrades and Downgrades

TRUP has been the subject of several recent analyst reports. Northland Securities raised their price target on Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a report on Thursday. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Bank of America increased their price target on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday. Piper Sandler boosted their price objective on shares of Trupanion from $30.00 to $38.00 and gave the stock a “neutral” rating in a report on Friday, August 9th. Finally, William Blair assumed coverage on shares of Trupanion in a research report on Friday, July 19th. They set an “outperform” rating on the stock. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Trupanion currently has an average rating of “Moderate Buy” and a consensus target price of $39.00.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $42.80 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The company’s 50-day moving average price is $40.56 and its 200 day moving average price is $31.72. Trupanion, Inc. has a 52 week low of $19.14 and a 52 week high of $49.14. The stock has a market cap of $1.80 billion, a price-to-earnings ratio of -66.88 and a beta of 1.74.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The business had revenue of $314.80 million for the quarter, compared to analyst estimates of $309.33 million. During the same period in the prior year, the business earned ($0.33) earnings per share. The company’s quarterly revenue was up 16.3% on a year-over-year basis. As a group, research analysts forecast that Trupanion, Inc. will post -0.37 earnings per share for the current fiscal year.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.